Overview
- Sheikh Hamdan bin Mohammed chaired the Dubai Longevity Authority’s first meeting and formally approved its strategy and operating budget on Sunday.
- The approved plan projects roughly 31% annual growth and aims to contribute more than Dh35 billion (about $9.53 billion) to Dubai’s economy over the next decade.
- The strategy lays a phased roadmap that moves the sector from research into licensed activity and commercial markets, covering R&D, clinical trials and manufacturing.
- Authority leaders say governance and regulatory direction have been established and that pilot programmes will offer supervised environments for innovators to test and scale longevity solutions.
- The DLA’s launch builds on regional life‑science moves such as Abu Dhabi’s 2025 precision medicine push and could draw global investment, clinical talent and new health‑care jobs to Dubai while targeting longer, healthier working lives for residents.